TheJobsMapVyro Bio jobs and careers
São Paulo, Brazil
About Vyro Bio
Vyro develops oncolytic viruses designed to target CNS tumors, based on pioneering research on the oncolytic properties of the Zika Virus.
Founded in 2021 by Carolini Kaid and Hugo Cabrera.
- Founded
- 2021
- Employees
- 11 to 50
- Total funding
- $1.5M
- Headquarters
- São Paulo
Leadership
The top of Vyro Bio's org chart, with how many people report into each leader.
HC
Hugo Cabrera
CEO & Co-Founder
5 reports
NS
Natan Siegel
Manufacturing Manager
4 reports
Board
ML
Marcia De Souza Lima
Scientific Advisor
CC
Caroline Chaul
Medical Advisor
EG
Ernesto Goulart
Co-Founder
MZ
Mayana Zatz
Co-founder & Scientific Advisor
KO
Keith Okamoto
Cofounder & Board Member
HB
Harry Bulstrode
Scientific Advisor
Jobs at Vyro Bio
No open positions right now. Explore more companies on TheJobsMap.